Pro Medicus’s FY25 results prove the company is cementing its position as a dominant player in its total addressable market, ...

The telco giant beat profit expectations but follows other big ASX peers downwards following mixed FY25 results.

Forget sentient robots or cures for cancer, AI’s single notable achievement so far has been to prop up a stock market that, ...

Forget sentient robots or cures for cancer, AI’s single notable achievement so far has been to prop up a stock market that, ...

As Scott Bessent recently highlighted, change is constant for investors as governments increasingly participate in economies ...

Commonwealth Bank ( ASX: CBA) took a rare 6.3% dive in early trade, despite reporting a relatively sound FY25 result. After ...

We're excited to announce Macquarie’s Viktor Shvets as an international guest speaker at Livewire Live 2025.

Markets have shrugged off chaos in 2025. Scott Berg explains why - and where he’s finding growth without chasing hype.

In fact, Robertson argues that “SMAs are the single best innovation we’ve had for retirees. Being able to build shares in ...

These ten charts highlight the key themes we're watching - where growth is slowing, where risks are rising, and why ...

Mid-cap stocks sit in the alpha sweet spot — with better growth than large caps, but lower risk than small ones.

From a fundraising slump to a secondaries boom, here's where Gabriel Ng of Neuberger Berman sees opportunity now.